Vol. 113, No. 1, 1983 May 31, 1983
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS Pages 280-285
OBLIGATORY ROLE OF A TRIS/CHOLINE ALLOSTERIC SITE IN GUANINE NUCLEOTIDE REGULATION OF [3H]-L-QNB BINDING TO MUSCARINIC ACETYLCHOLINE RECEPTORS Kenneth
M.M. Murphy
and Antonio
Sas.tre*
Departments of Neuroscience and Physiology Johns Hopkins University School of Medicine 725 North Wolfe Street Baltimore, Maryland 21205 Received
March
21,
1983
Tris and choline reduce the maximal binding capacity (RT) of the mu carinic cholinergic antagonist [3H]-L-quinuclidinyl benzilate ([ s HI-L-QNB) to atria1 membranes, when compared to control values in physiological salt solution (PBS) or NaPi buffer. Addition of guanine nucleotides (GN) to incubations containing choline or Tris reverses the effect of choline and Tris on RT and restores it to levels determined in NaPi or GN addition fails to alter RT or KD values determined in PBS alone. NaPi or PBS in the absence of choline and Tris. This GN effect follows a nucleotide specificity similar to that of the GN regulatory proteins coupled Tris or choline are required for the expression of GN to adenylate cyclase. regulation of [3H]-L-QNB binding to muscarinic acetylcholine receptors An allosteric site recognizing choline and Tris appears involved in (mAChR). the interaction between the guanine nucleotide regulatory protein and antagonist binding to mAChR.
Guanine agonist
nucleotides
binding
Two or three isotherms
to the myocardial agonist
obtained
non-hydrolizable to the
mAChR, long group
sites
are
in the
form
we and others regarded
muscarinic necessary
absence
GTP analog
low affinity
Recently
(GN) and Na+ have well
Gpp(NH)p,
to regulation
*To whom all
correspondence
to account
the
effects
acetylcholine
of GN (4,5);
receptor
for
the
complex
in the presence
agonist
(1,2,3)
sites
have suggested
by ionic should
that
population, strength,
the
binding
of the
predominantly
antagonist are
sites
in fact
GN, choline
convert
in the
a heterogeneous
and Tris,
and
be addressed.
mAChR, muscarinic acetylcholine receptor; QNB, quinuclidinyl Abbreviations: benzilate; PBS, physiologic buffer solution; Gpp(NH)p, 5'guanylimidodiphosphate; GN, guanine nucleotides; RT, maximal binding capacity. 0006-291X/83 $1.50 Copyright 0 1983 by Academic Press, Inc. All rights of reproduction in any form reserved.
280
on
(mAChR).
(1,2,3).
as a homogeneous
subject
documented
8lOCHEMlCAL
Vol. 113, No. 1, 1983
monovalent
ions
et a . (7)
.
observations
proposed
Their
of sites
for
an d a decreased
antagonists
The interconversion
to adenylate
of this
effect
was not
Here we report
affinity
that
GN regulation
solutions,
an increased
agonists
in the
by a guanine the
of antagonist
is not
or exogenous
follows
nucleotide
displays
although
of a previously
such regulation of Tris
(9),
some of
reciprocal
for
mediated
cyclase
to integrate
affinity
presence
of GN.
nucleotide
regulatory
nucleotide
specificity
defined.
the occupation
(8)s and that
guanine
and have not
a GN-mediated
the receptor
was presumably
linked
Tris
are complex
model
postulated
in which
protein
the absence
interactions
an intriguing
model
interconversion
requires
RESEARCH COMMUNICATIONS
elucidated.
Burgisser these
These multiple
(6,7,8).
been completely
AND BIOPHYSICAL
choline.
This
effect,
linked
to adenylate
Materials
site
buffers
present
similar
mAChR
regulatory
in physiologic
specificity
proteins
to the
choline/Tris
demonstrable
a nucleotide
regulatory
defined
binding
in
in choline
to that
or
of the
cyclase
(9).
and Methods
Hearts were excised from mongrel dogs, CD rats, CD-l mice and Rana pipiens frogs and prepared as described (8). The homogenate was wire meshmiltered, centrifuged and 50 ~1 of the resuspended pellet was added to a final volume of 1 ml containing [3H]-L-QNE, drugs, nucleotides and buffer. Buffers used included a physiologic salt solution (PBS) (Dulbecco's phosphate-buffered saline, containing in mM: NaCl, 138; KCl, 2.6; CaC12, 1.0; MgS04, 0.5; Na2HPD4, 8; and KH2P04, 1.5), 50 mN NaPi or 50 mM Tris-HCl, all at pH 7.4 at 25'C. Incubations, filtrations and counting were carried out as Adenine and guanine nucleotides were obtained as Na previously described (8). salts from Sigma. Results As previously [3H]-L-QNB Tris
to myocardial
reveals
to parallel Addition
described
(8), tissue
a significantly experiments
carried reduced
carried
of GN restores
the
out
reduced
determined
in PBS and NaPi.
determined
in PBS or NaPi buffer.
of 213 L 10 fmol/mg exogenous
GN exhibited
Scatchard
protein.
analysis out
in the presence
maximal
binding
isotherms of choline
capacity
(RT)
(Figure
1).
RT determined
to the
levels
failed
Membranes
Membranes
281
to alter
assayed
assayed
apparent
in Tris
RT (68O/0
or
RT values
in NaPi displayed
in Tris
of
compared
in PBS or NaPi buffer
GN additions
a reduced
of binding
in the
of control),
absence which
an RT of was
Vol. 113, No. 1, 1983
BIOCHEMICAL
AND BIOPHYSICAL
[3~]~~~ Figure
to control
concentration
Tris compared
values
in the
of GN increased
1 and Table caused
presence
the
a 3-fold
increase determined
approaching
in NaPi
in the K,, for
[3~]-~-~~~
for
of similar
ionic
1).
Gpp(NH)p
that
measured Table
Effects Atria1
This
RT determined
in NaPi buffer
52 + 10 pM; Table
to a value
of
of 100 UM Gpp(NH)p. by only
of Gpp(NH)p on Affinity Homogenates for [3H]-L-QNB
at lo-100 in NaPi,
the mAchR
not
and Maximal Assayed in
RT ('I'
control)
52 -+ 10
100
NaPi
+ Gpp(NH)p
46+
7
109 + 3
153 + 20
68 + 3
81 + 12
111 +- 5
KB values from
are
Scatchard
the
mean
z S.E.M.
The
concentration
presented
analysis
as mean of
of
the
of
Gpp(NH)p
+ S.E.M.
binding
percent
isotherms. of
was
control
100
PM.
282
affecting
Binding Capacity NaPi and Tris Buffer
(control)
+ tipp(NH)p
the KD
1
NaPi
Tris
strength
uM increased while
Ko (PM)
Tris
9"/e
1).
to KD values
(153 + 20 vs. in Tris
(fmol/mg)
1 Scatchard plot of [3H]-L-QNB binding to canine atria1 membranes in NaPi buffer without Gpp(NH)p (o), or with 100 uM Gpp(NH)p (0); in Tris buffer without Gpp(NH)p (I) or with 100 UM Gpp(NH)p (U). Total and blank incubations were carried out in duplicate in the absence or presence of 1 UM atropine respectively, with 50 ~1 of identical membrane suspension in a total volume of 1 ml. [3H]-L-QNB concentration was varieo between 80 pM and 2 nM. These experiments were replicated 5 times with similar results.
restored
(Figure
bound
RESEARCH COMMUNICATIONS
for
5-6
experiments
RT values
are
RT determined
in
determined expressed NaPi
buffer.
as
the
Vol. 113, No. 1, 1983
Figure
in
increases
(2
the
NaPi
shown).
Studies
were
to
determine Tris,
increase
in
[3H]-L-QNB an
in
alone. stable
in
GTP
and
of binding
(Figure
but
not
nucleotide to
the
GDP
and
Gpp(NH)p
100
PBS
in
their
PM.
for
a dose
the
R,
dependent
1 mM choline,
results
this in
alter
were
obtained
an ECSO adenine
NaPi
binding
with
30
more nM
nucleotides
283
(Figure
restoration
buffer
(Figure
in
measured at
lo-fold of
GN-mediated
measured
restoration
about
The
on
NaPi.
binding
not
[3~]-~-~~~
nucleotides
of
and
isotherms
of
caused
Similar
RT
binding
presence
determined
do
is with
the
2). in
levels
adenine
Gpp(NH)p
specificity
produced
binding,
GN and
[3H]-L-QNB
buffer,
at
in
the
the
concentrations
buffer.
RT
restore
analog
restoration restore
RESEARCH COMMUNICATIONS
reduces of
saturating of
NaPi
in
Tris
NaPi
GTP
and
choline analysis
influences
buffer,
GDP completely
measured
with
binding
the in
Similarly, Scatchard
out
increase
We examined
and
PBS
Tris,
RT measured
in
the
in
reflecting
1).
carried
measured
Gpp(NH)p
(Table
KD measured
not
nM)
AND BIOPHYSICAL
2 The influence of Gpp(NH)p on [3H]-L-QNB binding to atria1 membranes in the absence or presence of choline. Dose response curves for the effect of Gpp(NH)p on [3H]-L-QNB binding to atria1 membranes were constructed using 50 ~1 tissue homogenate in NaPi buffer in the absence (0) or the presence (a) of 1 &I choline. [3H]-L-QNB was 2 nM throughout and total and nonspecific binding were determined for each condition by the absence or presence of 1 UM atrogine. No effect on blank values was observed. Results are presented as the I' restoration from binding observed in the presence of choline without Gpp(NH)p additioti, to the binding observed in NaPi without choline addition. Typically, specific binding in the presence of choline was 1300 cpm/50 ~1 tissue (taken as O'/' restoration) and was restored to 2000-2200 cpm/50 ~1 tissue (approximately 80'1' restoration). Binding in NaPi buffer alone was 2200-2400 cpm and is defined as lOO'/' restoration. The values are the mean of 4 independent determinations. -+ S.E.M.
KD measured
(data
BIOCHEMICAL
Tris
to
in
NaPi
approximately potent
ATP,
buffer
GTP
GMP ADP
and
GTP
that
300
than 3).
3).
of
nM. in
fails AMP
The
its to have
no
Vol. 113, No. 1, 1983
BIOCHEMICAL
AND BIOPHYSICAL
-log [Nucleotide] Figure
RESEARCH COMMUNICATIONS
(MI
3The influence of guanine nucleotides on [3H]-L-(INB binding in NaPi buffer or Tris. Dose response curves for Gpp(NH)p (o), GTP (I ), GDP (D), and GMP (A) were constructed using 2 nM [3H]-L-QNB with 50 ~1 membrane suspension incubated in a volume of 1 ml Tris Buffer. Dose-response curves constructed in NaPi buffer for Gpp(NH)p (0) and GTP (A) showed no effect on total or blank binding levels. Results are presented as the percent restoration from binding in Tris to the binding observed in NaPi buffer alone, as described in Figure 2. Values presented are the mean + SEM of 4 independent determinations.
effect
on [3H]-L-QNB
1O-8 M to lo4
binding
M (data
in Tris
not
or NaPi buffer
at concentrations
of
shown). Discussion
The major binding
finding
of the
to the mAChR is
present
absolutely
In PBS or NaPi buffer,
Tris.
C3H]-L-QNB
to atria1 the
the
isotherms
binding
choline
RT
or Tris
cannot
to
simply
apparent
GN regulation
on the
in the in
that
that
presence
to influence
whereas
observed
confirms
is on the
be explained
GN failed
levels
is
dependent
membranes,
GN restored
study
the
PBS
RT, and the
as a reduction
presence
alone.
action
the
of antagonist of choline
binding
in affinity
or Tris,
analysis
of GN in the action
of
of choline
Scatchard
or
presence
of
of
of the
nucleotides
of the
receptor
for
the
ligand. We previously Tris
which
distinct
regulates from
Approximately and Tris observations,
reported
presence
antagonist
previously one half
regulation
the
of an allosteric
binding
described of the
to the mAChR (8).
agonist
antagonist
or antagonist sites
in a non-competitive
we postulated
site
manner
a heterogeneity
mAChR.
284
appeared (8).
of antagonist
This binding sensitive
for
choline site
and
is
sites. to choline
Based on these sites
within
the
Vol. 113, No. 1, 1983 In this
report
an obligatory binding
we show that
feature
for
to the mAChR.
substitute
for
illustrated rats
BIOCHEMICAL
the expression
or Tris
for
canine
and mice and in atria
used by Burgisser effect
occupation
of this
(7)).
this
membranes,
and ventricles
et al.
site
and di-valent
in allowing
atria1
RESEARCH COMMUNICATIONS by choline
of GN regulation
None of the mono-
choline
here
AND BIOPHYSICAL
ions
also
of frogs
The widespread
present This
observed
in PBS can phenomenon,
in atria
(Rana pipiens;
biologic
is
of antagonist
expression. is
or Tris
the
expression
from species
of this
is evident. The obligatory
involvement
regulation
of antagonist
and models
(7,
We cannot allosteric
site
resides
yet
undefined
clarify
the
(9).
role
a re-examination
a further
constraint
data
site
nor the
exact
information
is
More
the mAChR, with
component
choline/Tris
present
regulatory
protein within
the
allosteric
suggests
and imposes
from
choline
GN regulatory
binding
8, lo),
determine
of the
receptor
allosteric
site
in GN
of available on plausible location
needed
of the
to determine protein,
complex, in cholinergic
data models.
mode of interaction
the GN regulatory
of the functional
of GN and this
the molecular
site
with if
the
this
or another as well
as
as to
transmission.
Acknowledgements We acknowledge gratefully the skillful technical assistance of Mrs. Colenda and Mrs. J. Simkins. This work was supported by grant HL-22675 A.S. and Medical Scientist Training Program grant GM-07309 (K.M.M.M.).
K. to
References 1.
Rosenberger, L.B., Yamamura, H.I., and Roeske, W.R. (1980) J. Biol. Chem. 255, 820-823. 2. Berrie, C.P., Birdsall, N.J.M., Burgen, A.S.U., and Hulme, E.C. (1979) Biochem. Biophys. Res. Comnun. 87, 1000-1005. Wei, J.W. and Sulakle, P.V. (1979) Eur. J. Pharmacol. 58, 91-92. i: Burgen, A.S.V. and Hulme, E.C. (1978) Mol. Pharmacol. 14, Birdsall, N.J.M., 723-736. 5. Birdsall, N.J.M., Hulme, E.C. and Burgen, A.S.V. (1980) Proc. R. Sot. Lond. 8207, 1-12. 6. Hulme, E.C., Berrie, C.P., Birdsall, N.J.M. and Burgen, A.S.V. (1981) Eur. J. Pharmacol. 73, 137-142. 7. Burgisser, E., DeLean, A. and Lefkowitz, R.J. (1982) Proc. Nat'l. Acad. Sci. 79, 1732-1736. 8. Sastre, A., Murphy, K.M.M. and Rusher, M.M. (1982) Biochem. Biophys. Res. Commun. 104, 383-388. 9. Rodbell, M. (1980) Nature 284, 17-22. 10. Hosey, M.M. (1982) Biochem. Biophys. Res. Commun 107, 314-321. 285